944 related articles for article (PubMed ID: 9041462)
1. HLA class I antigens in Japanese patients with melanoma.
Kageshita T; Naruse T; Hirai S; Horikoshi T; Nakagawa H; Tamaki K; Hayashibe K; Ichihashi M; Nakayama J; Hori Y; Ozawa A; Miyahara M; Ohkido M; Inoko H; Ono T
J Immunother Emphasis Tumor Immunol; 1996 Nov; 19(6):428-32. PubMed ID: 9041462
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between HLA-E polymorphism and primary cutaneous melanoma in Spanish patients.
Moya-Quiles MR; Martínez-Escribano J; Guerra-Perez N; Muro M; Marín L; Campillo JA; Montes-Ares O; Frias J; Minguela A; García-Alonso AM; Lozano JA; Alvarez-López MR
J Dermatol Sci; 2005 Oct; 40(1):62-4. PubMed ID: 16153808
[No Abstract] [Full Text] [Related]
3. HLA-G expression in malignant melanoma.
Rebmann V; Wagner S; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
[TBL] [Abstract][Full Text] [Related]
4. The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.
Kandilarova SM; Paschen A; Mihaylova A; Ivanova M; Schadendorf D; Naumova E
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):73-81. PubMed ID: 28083606
[TBL] [Abstract][Full Text] [Related]
5. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
Kim CJ; Parkinson DR; Marincola F
J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
[TBL] [Abstract][Full Text] [Related]
6. HLA allele frequency and clinical outcome in Italian patients with cutaneous melanoma.
Luongo V; Pirozzi G; Caracò C; Errico S; de Angelis F; Celentano E; Paino F; Chiofalo MG; Luongo M; Mozzillo N; Lombardi ML
Tissue Antigens; 2004 Jul; 64(1):84-7. PubMed ID: 15191529
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity in expression of human leukocyte antigens and melanoma-associated antigens in advanced melanoma.
Ohnmacht GA; Marincola FM
J Cell Physiol; 2000 Mar; 182(3):332-8. PubMed ID: 10653599
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic analysis of HLA class II alleles in Japanese patients with melanoma.
Kageshita T; Naruse T; Hirai S; Ono T; Horikoshi T; Nakagawa H; Tamaki K; Hayashibe K; Ichihashi M; Nakayama J; Hori Y; Ozawa A; Miyahara M; Ohkido M; Inoko H
Tissue Antigens; 1997 May; 49(5):466-70. PubMed ID: 9174138
[TBL] [Abstract][Full Text] [Related]
9. HLA-G expression in human melanoma cells: protection from NK cytolysis.
Adrián Cabestré F; Moreau P; Riteau B; Ibrahim EC; Le Danff C; Dausset J; Rouas-Freiss N; Carosella ED; Paul P
J Reprod Immunol; 1999 Jul; 43(2):183-93. PubMed ID: 10479054
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of human leukocyte antigen-E gene in the Japanese population with or without recurrent abortion.
Kanai T; Fujii T; Keicho N; Tokunaga K; Yamashita T; Hyodo H; Miki A; Unno N; Kozuma S; Taketani Y
Am J Reprod Immunol; 2001 Mar; 45(3):168-73. PubMed ID: 11270642
[TBL] [Abstract][Full Text] [Related]
11. Putative linkage between HLA class I polymorphism and the susceptibility to malignant melanoma.
Ichimiya M; Muto M; Hamamoto Y; Ohmura A; Tateno H; Asagami C
Australas J Dermatol; 1996 May; 37 Suppl 1():S39. PubMed ID: 8713011
[TBL] [Abstract][Full Text] [Related]
12. Analysis of human leukocyte antigen (HLA)-G polymorphism in normal women and in women with recurrent spontaneous abortions.
Abbas A; Tripathi P; Naik S; Agrawal S
Eur J Immunogenet; 2004 Dec; 31(6):275-8. PubMed ID: 15548266
[TBL] [Abstract][Full Text] [Related]
13. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
Kageshita T; Ishihara T; Campoli M; Ferrone S
Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
[TBL] [Abstract][Full Text] [Related]
14. HLA-B8 association with late-stage melanoma--an immunological lesson?
Fensterle J; Trefzer U; Berger T; Andersen MH; Ugurel S; Becker JC
BMC Med; 2006 Mar; 4():5. PubMed ID: 16533402
[TBL] [Abstract][Full Text] [Related]
15. [Analysis on HLA-E polymorphism in Shanghai Han population].
Zhao L; Fan L; Yang J; Yao F; Xu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):444-7. PubMed ID: 11774212
[TBL] [Abstract][Full Text] [Related]
16. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
[TBL] [Abstract][Full Text] [Related]
17. Normal HLA class I, II, and MICA gene distribution in uveal melanoma.
Metzelaar-Blok JA; Hurks HM; Naipal A; De Lange P; Keunen JE; Claas FH; Doxiadis II; Jager MJ
Mol Vis; 2005 Dec; 11():1166-72. PubMed ID: 16379028
[TBL] [Abstract][Full Text] [Related]
18. Decreased intraindividual HLA class I expression is due to reduced transcription in advanced melanoma and does not correlate with HLA-G expression.
Willers J; Urosevic M; Laine E; Geertsen R; Kündig T; Burg G; Dummer R
J Invest Dermatol; 2001 Dec; 117(6):1498-504. PubMed ID: 11886514
[TBL] [Abstract][Full Text] [Related]
19. HLA associations in the antitumor response against malignant melanoma.
Marincola FM; Shamamian P; Rivoltini L; Salgaller M; Cormier J; Restifo NP; Simonis TB; Venzon D; White DE; Parkinson DR
J Immunother Emphasis Tumor Immunol; 1995 Nov; 18(4):242-52. PubMed ID: 8680652
[TBL] [Abstract][Full Text] [Related]
20. HLA-G gene polymorphism in a Japanese population.
Yamashita T; Fujii T; Watanabe Y; Tokunaga K; Tadokoro K; Juji T; Taketani Y
Immunogenetics; 1996; 44(3):186-91. PubMed ID: 8662085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
